Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Closing of Global Offering and resulting TVR

July 21, 2020
RNS Number : 6782T Renalytix AI PLC 21 July 2020         Renalytix AI plc   Closing of Global Offering and resulting total voting rights   Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX) (" RenalytixAI " or the " Company "), an artificial intelligence -enabled   in vitro   diagnostics company,

Pricing of Global Offering

July 17, 2020
RNS Number : 3256T Renalytix AI PLC 17 July 2020         This announcement contains inside information   Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction  

Result of General Meeting

July 13, 2020
Download  full announcement Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled  in vitro  diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that all resolutions proposed at the
Displaying 121 - 130 of 203